You are here

Home

Icagen, Inc.

Company Information
Address
4222 EMPEROR BLVD STE 350
DURHAM, NC 27703-8030
United States
Information

UEI: N/A

# of Employees: 12
Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No

Award Charts




Award Listing

  • Record 1 TO 20

  1. Biomolecular Taggants for Covert Tracking and Watermarking

    Amount: $100,000.00

    Caldera will use its R&D 100 award-winning XRpro technologyto develop functional biomolecular taggants for Chemical/Biological/Radiological/Nuclear/Explosive (CBRNE) targets. These taggants will poss ...

    SBIRPhase I2008Department of Defense Air Force

  2. Generation of Peptide-Based Ligands for Chemical and Biological Agent Identification

    Amount: $100,000.00

    Caldera will use its R&D 100 award-winning Reagentless Pharmacoproteomic Measurement (RPM) technology to develop chemical/biological (C/B) agent taggants for incorporation into a portable read-out dev ...

    SBIRPhase I2007Department of Defense Air Force

  3. Novel Micro-X-ray Translucent Flow Cell Technology for Proteomics, a Broadly Appl

    Amount: $179,696.00

    DESCRIPTION (provided by applicant): Caldera Pharmaceutical's aim is to develop a broadly applicable, quantitative research tool which addresses core technical challenges in the field of proteomics, i ...

    SBIRPhase I2007Department of Health and Human Services National Institutes of Health

  4. Biomarkers of Response to Environmental Stressors: Measurement of Environmental E

    Amount: $299,999.00

    DESCRIPTION (provided by applicant) Caldera Pharmaceutical's will use their unique, R&D100-award-winning Reagentless Pharmacoproteomic Measurement (RPM) high-throughput technology to identify b ...

    SBIRPhase I2007Department of Health and Human Services National Institutes of Health

  5. Adherence Assessment for Supplements

    Amount: $375,000.00

    DESCRIPTION (provided by applicant): Caldera Pharmaceuticals uses protein fractionation techniques and XRpro technology to determine protein CAM/metabolite binding as a means to determine adherence t ...

    SBIRPhase II2007Department of Health and Human Services National Institutes of Health

  6. High-throughput Direct Structural Screening for Drug Lead Compounds

    Amount: $100,000.00

    U.S. Government personnel deployed in tropical and neotropical regions continue to be at risk for developing malaria. Drug resistant malaria parasites are becoming more common in these areas, increasi ...

    STTRPhase I2006Department of Defense Army

  7. Chemical and Biological Agent Deny: Selective Phosphate Ester Hydrolysis

    Amount: $99,985.00

    This proposed work will generate a targeted phosphate ester hydrolysis catalyst for agent denial. This catalyst will be targeted by conjugation to single stranded DNA. Characteristics of the catalyst ...

    SBIRPhase I2006Department of Defense Defense Threat Reduction Agency

  8. Adherence Assessment for Supplements

    Amount: $245,093.00

    DESCRIPTION (provided by applicant): The use of dietary supplements has become increasingly popular in the US, and these supplements are not subject to stringent pre-marketing testing or post-marketin ...

    SBIRPhase I2006Department of Health and Human Services National Institutes of Health

  9. FUNCTIONAL ASSAYS FOR ION CHANNEL DRUG TARGETS

    Amount: $588,877.00

    N/A

    SBIRPhase II1997Department of Health and Human Services

  10. FUNCTIONAL ASSAYS FOR ION CHANNEL DRUG TARGETS

    Amount: $99,147.00

    N/A

    SBIRPhase I1996Department of Health and Human Services
US Flag An Official Website of the United States Government